These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29115606)
21. Leptin-elicited miRNA-342-3p potentiates gemcitabine resistance in pancreatic ductal adenocarcinoma. Ma L; Fan Z; Du G; Wang H Biochem Biophys Res Commun; 2019 Feb; 509(3):845-853. PubMed ID: 30638935 [TBL] [Abstract][Full Text] [Related]
22. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003 [TBL] [Abstract][Full Text] [Related]
23. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer. Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201 [TBL] [Abstract][Full Text] [Related]
24. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372 [TBL] [Abstract][Full Text] [Related]
25. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway. Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183 [TBL] [Abstract][Full Text] [Related]
26. Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma. Gifford JB; Huang W; Zeleniak AE; Hindoyan A; Wu H; Donahue TR; Hill R Mol Cancer Ther; 2016 May; 15(5):1043-52. PubMed ID: 26939701 [TBL] [Abstract][Full Text] [Related]
27. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352 [TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. Zhang X; Yashiro M; Ren J; Hirakawa K Oncol Rep; 2006 Sep; 16(3):563-8. PubMed ID: 16865256 [TBL] [Abstract][Full Text] [Related]
29. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma. Liau SS; Ashley SW; Whang EE J Gastrointest Surg; 2006 Nov; 10(9):1254-62; discussion 1263. PubMed ID: 17114012 [TBL] [Abstract][Full Text] [Related]
30. Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data. Airoldi M; Cattel L; Passera R; Pedani F; Delprino L; Micari C Am J Clin Oncol; 2006 Oct; 29(5):490-4. PubMed ID: 17023785 [TBL] [Abstract][Full Text] [Related]
31. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma. Wang L; Wang F; Na L; Yu J; Huang L; Meng ZQ; Chen Z; Chen H; Ming LL; Hua YQ Cancer Biomark; 2018; 22(1):169-174. PubMed ID: 29526843 [TBL] [Abstract][Full Text] [Related]
32. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106 [TBL] [Abstract][Full Text] [Related]
34. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells. Lan CY; Chen SY; Kuo CW; Lu CC; Yen GC J Food Drug Anal; 2019 Oct; 27(4):887-896. PubMed ID: 31590760 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of AKT sensitizes chemoresistant ovarian cancer cells to cisplatin by abrogating S and G2/M arrest. Zhang D; Piao HL; Li YH; Qiu Q; Li DJ; Du MR; Tsang BK Exp Mol Pathol; 2016 Jun; 100(3):506-13. PubMed ID: 27163202 [TBL] [Abstract][Full Text] [Related]
36. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer. Wang C; Huang H Biochem Biophys Res Commun; 2021 Nov; 579():181-187. PubMed ID: 34624736 [TBL] [Abstract][Full Text] [Related]
37. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594 [TBL] [Abstract][Full Text] [Related]
38. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522 [TBL] [Abstract][Full Text] [Related]
39. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer. Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Wang TX; You L; Shu H Arch Med Res; 2014 Jan; 45(1):15-20. PubMed ID: 24316112 [TBL] [Abstract][Full Text] [Related]
40. Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer. Onishi H; Morifuji Y; Kai M; Suyama K; Iwasaki H; Katano M Cancer Sci; 2012 Jul; 103(7):1272-9. PubMed ID: 22486854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]